HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2018

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis

Franck Vitte
  • Fonction : Auteur
Isabelle Plo

Résumé

Heat shock protein 27 (HSP27/HSPB1) is a stress-inducible chaperone that facilitates cancer development by its proliferative and anti-apoptotic functions. The OGX-427 antisense oligonucleotide against HSP27 has been reported to be beneficial against idiopathic pulmonary fibrosis. Here we show that OGX-427 is effective in two murine models of thrombopoietin- and JAKV617F-induced myelofibrosis. OGX-427 limits disease progression and is associated with a reduction in spleen weight, in megakaryocyte expansion and, for the JAKV617F model, in fibrosis. HSP27 regulates the proliferation of JAK2V617F-positive cells and interacts directly with JAK2/STAT5. We also show that its expression is increased in both CD34+ circulating progenitors and in the serum of patients with JAK2-dependent myeloproliferative neoplasms with fibrosis. Our data suggest that HSP27 plays a key role in the pathophysiology of myelofibrosis and represents a new potential therapeutic target for patients with myeloproliferative neoplasms.

Domaines

Cancer
Fichier principal
Vignette du fichier
s41467-018-03627-9.pdf (2.3 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-01864299 , version 1 (10-06-2021)

Licence

Paternité

Identifiants

Citer

Margaux Sevin, Lucia Kubovcakova, Nicolas Pernet, Sebastien Causse, Franck Vitte, et al.. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nature Communications, 2018, 9 (1), pp.1431. ⟨10.1038/s41467-018-03627-9⟩. ⟨hal-01864299⟩
210 Consultations
121 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More